Studies on effectiveness of the Chinese medicine against intractable mycobacterial infection
中药治疗顽固性分枝杆菌感染的疗效研究
基本信息
- 批准号:18590653
- 负责人:
- 金额:$ 2.49万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We examined the effects of immunomodulating agents including various Chinese traditional medicines in potentiating of the host antimicrobial functions against Mycobacterium avium complex (MAC) infection. The following findings were obtained. (1) Mao-Bushi-Saishin-To (MBST) enhanced the macrophage (Mφ) anti-MAC activity. However, forty-five other Chinese traditional medicines did not exhibit such significant effects except for weak effect by Ma-Kyou-Yoku-Kan-To in potentiating anti-MAC activity of host Mφs. Thus, it appears that the efficacy in increasing of the Mφ antimicrobial activity against intracellular MAC by directly augmenting Mφ and/or lymphocyte functions is generally weak in case of most Chinese medicines. (2) The production of reactive oxygen intermediate (ROI) by various types of Mφs were weak induced by MBST treatment except for Kakkon-To. (3) These effects were found only when Mφs were pre-treated with test Chinese traditional medicine in plastic wells. Therefore, it is … More likely that there are significant differences in the mode of signal transduction in MBST-activated Mφs which depend on intensity of cell-matrix adhesion. (4) Treatment of Mφs with ATP, which potentiate Mφ anti-MAC activity, in combination with MBST did not significantly increase the production of reactive nitrogen intermediate by Mφs. (5) Concanavalin A (Con A)-induced T cell mitogenic responses were significantly inhibited by Ouren-Gedoku-To and Hochu-Ekki-To, while inhibitory efficacy of MBST was weaker than them. On the other hand, other 17 Chinese traditional medicines did not exhibit such effect on T cell Con A mitogenesis. (6) As the first step in the development of in vitro experimental systems to regulate various Mφ functions by using siRNA, we examined whether Mφ suppressor activity could be controlled by using antisense oligonucleotides specific to PD-L. There was observed the tendency that Mφ suppressor activity was decreased to some extent by the PDL-specific antisense oligonucleotides. (7) We focused on picolinic acid (PA), a natural organic product, as an immunomodulator better than Chinese traditional medicines. We found that PA potentiated Mφ antimicrobial activity against intracellular MAC. In addition, PA induced the early phase apoptotic events in THP-1 Mφs, without inducing DNA fragmentation characteristic to the middle to late phase apoptosis. Less
本文研究了多种中药等免疫调节剂对鸡分枝杆菌复合群(MAC)感染的增强作用。获得了以下结果。(1)MBST能增强巨噬细胞(M φ)抗MAC活性。而除麻圭郁坎藤对宿主M φ的抗MAC活性有较弱的增强作用外,其余45种中药均未表现出明显的抗MAC活性。因此,似乎在大多数中药的情况下,通过直接增强M φ和/或淋巴细胞功能来增加M φ抗细胞内MAC的抗微生物活性的功效通常较弱。(2)MBST对除Kakkon-To外的各型M φ产生活性氧中间产物(ROI)的诱导作用均较弱。(3)这些作用仅在用中药预处理的塑料威尔斯孔中发现。因此有 ...更多信息 MBST激活的M φ的信号传导模式可能存在显着差异,这取决于细胞与基质粘附的强度。(4)ATP可增强M φ的抗MAC活性,但与MBST联合处理M φ并不能显著增加M φ产生活性氮中间产物。(5)伴刀豆球蛋白A(ConA)诱导的T细胞有丝分裂反应被Ouren-Gedoku-To和Hochu-Ekki-To显著抑制,而MBST的抑制效果弱于它们。另一方面,其他17种中药对T细胞Con A有丝分裂无明显影响。(6)作为开发利用siRNA调控各种M φ功能的体外实验系统的第一步,我们检测了是否可以通过使用PD-L特异性的反义寡核苷酸来控制M φ抑制剂活性。PDL特异性反义寡核苷酸有降低M φ抑制活性的趋势。(7)本论文重点研究了吡啶甲酸(PA)作为一种天然有机产物,作为一种比传统中药更好的免疫调节剂。我们发现PA增强了M φ对细胞内MAC的抗菌活性。此外,PA诱导THP-1 M φ的早期凋亡事件,而不诱导DNA断裂特征性的中晚期凋亡。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
[Review] Prospects on the development of new antituberculous drug regimens in the future
[综述]未来抗结核新药方案开发展望
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Tomioka;H.;Shimizu;T
- 通讯作者:T
[Review] Development of antituberculous drugs : current status and future prospects
[综述]抗结核药物的发展:现状与未来展望
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Tomioka;H.;Namba;K
- 通讯作者:K
Effects of various immunomodulators on the antimicrobial activity of clarithromycin in combination with rifampin against Mycobacterium avium complex within macrophages
不同免疫调节剂对克拉霉素联合利福平抗巨噬细胞内鸟分枝杆菌复合物抗菌活性的影响
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Tomioka H;Shimizu T;Sano C;Yamabe S;Hiraki M
- 通讯作者:Hiraki M
ピコリン酸によるマクロファージの抗MAC活性増強作用の発現メカニズムにおける遊離脂肪酸の役割
游离脂肪酸在吡啶甲酸诱导巨噬细胞抗MAC活性增强的表达机制中的作用
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:清水利朗;佐藤勝昌;冨岡治明
- 通讯作者:冨岡治明
[Review] Development of new antituberculous agents based on new drug targets and structure-activity relationship
[综述] 基于新药靶点和构效关系的新型抗结核药物开发
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Tomioka;H
- 通讯作者:H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANO Chiaki其他文献
SANO Chiaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANO Chiaki', 18)}}的其他基金
Proteomic analysis and genotyping of nontuberculosis mycobacteria to investigate effects of traditional Chinese medicines against pathogenesis
非结核分枝杆菌的蛋白质组学分析和基因分型研究中药对发病机制的影响
- 批准号:
25461159 - 财政年份:2013
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Genome-wide screening for host lncRNAs regulating host defense against Mycobacterial infection in macrophages
全基因组筛选调节宿主防御巨噬细胞分枝杆菌感染的宿主lncRNA
- 批准号:
10633283 - 财政年份:2022
- 资助金额:
$ 2.49万 - 项目类别:
Genome-wide screening for host lncRNAs regulating host defense against Mycobacterial infection in macrophages
全基因组筛选调节宿主防御巨噬细胞分枝杆菌感染的宿主lncRNA
- 批准号:
10526531 - 财政年份:2022
- 资助金额:
$ 2.49万 - 项目类别:
Ironing out mycobacterial persistence: Iron access and utilization in chronic mycobacterial infection
消除分枝杆菌的持久性:慢性分枝杆菌感染中铁的获取和利用
- 批准号:
10473802 - 财政年份:2020
- 资助金额:
$ 2.49万 - 项目类别:
Ironing out mycobacterial persistence: Iron access and utilization in chronic mycobacterial infection
消除分枝杆菌的持久性:慢性分枝杆菌感染中铁的获取和利用
- 批准号:
10444899 - 财政年份:2020
- 资助金额:
$ 2.49万 - 项目类别:
Ironing out mycobacterial persistence: Iron access and utilization in chronic mycobacterial infection
消除分枝杆菌的持久性:慢性分枝杆菌感染中铁的获取和利用
- 批准号:
10684122 - 财政年份:2020
- 资助金额:
$ 2.49万 - 项目类别:
Genetic dissection of angiogenesis during mycobacterial infection
分枝杆菌感染期间血管生成的基因剖析
- 批准号:
10576974 - 财政年份:2017
- 资助金额:
$ 2.49万 - 项目类别:
Genetic dissection of angiogenesis during mycobacterial infection
分枝杆菌感染期间血管生成的基因剖析
- 批准号:
10445415 - 财政年份:2017
- 资助金额:
$ 2.49万 - 项目类别:
The Genetic Basis of Bone Disease in Mycobacterial Infection
分枝杆菌感染引起的骨病的遗传基础
- 批准号:
8971952 - 财政年份:2014
- 资助金额:
$ 2.49万 - 项目类别:
The Genetic Basis of Bone Disease in Mycobacterial Infection
分枝杆菌感染引起的骨病的遗传基础
- 批准号:
8824043 - 财政年份:2014
- 资助金额:
$ 2.49万 - 项目类别:
Pro-resolving lipid mediators in mycobacterial infection
分枝杆菌感染中的促溶解脂质介质
- 批准号:
8591975 - 财政年份:2013
- 资助金额:
$ 2.49万 - 项目类别:














{{item.name}}会员




